(S (NP (NP (NNP Designing)) (NP (DT a) (JJ new) (NN drug))) (VP (VBZ is) (NP (DT a) (ADJP (JJ lengthy) (CC and) (JJ expensive)) (NN process))) (. .))
(S (SBAR (IN As) (S (NP (NP (DT the) (NN space)) (PP (IN of) (NP (JJ potential) (NNS molecules)))) (VP (VBZ is) (ADJP (RB very) (JJ large)) (PRN (-LRB- -LRB-) (NP (NP (CD 10)) (SYM ^) (NP (CD 23) (SYM -) (CD 10) (SYM ^) (CD 60))) (-RRB- -RRB-))))) (, ,) (NP (NP (DT a) (JJ common) (NN technique)) (PP (IN during) (NP (NN drug) (NN discovery)))) (VP (VBZ is) (S (VP (TO to) (VP (VB start) (PP (IN from) (NP (NP (DT a) (NN molecule)) (SBAR (WHNP (WDT which)) (S (ADVP (RB already)) (VP (VBZ has) (NP (NP (DT some)) (PP (IN of) (NP (DT the) (VBN desired) (NNS properties))))))))))))) (. .))
(S (NP (NP (DT An) (JJ interdisciplinary) (NN team)) (PP (IN of) (NP (NNS scientists)))) (VP (VBZ generates) (NP (NN hypothesis)) (PP (IN about) (NP (NP (DT the) (VBN required) (NNS changes)) (PP (IN to) (NP (DT the) (NN prototype)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP develop) (NP (NP (DT an) (JJ algorithmic) (JJ unsupervised) (HYPH -) (NN approach)) (SBAR (WHNP (WDT that)) (S (ADVP (RB automatically)) (VP (VBZ generates) (NP (NP (JJ potential) (NN drug) (NNS molecules)) (VP (VBN given) (NP (DT a) (NN prototype) (NN drug))))))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NNS molecules)) (VP (VBN generated) (PP (IN by) (NP (DT the) (NN system))))) (VP (VBP are) (UCP (NP (JJ valid) (NNS molecules)) (CC and) (ADJP (RB significantly) (JJ different) (PP (IN from) (NP (DT the) (NN prototype) (NN drug))))))))) (. .))
(S (PP (IN Out) (PP (IN of) (NP (NP (DT the) (NNS compounds)) (VP (VBN generated) (PP (IN by) (NP (DT the) (NN system))))))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (CD 35) (ADJP (NNP FDA) (HYPH -) (VBN approved)) (NNS drugs))) (. .))
(S (PP (IN As) (NP (DT an) (NN example))) (, ,) (NP (PRP$ our) (NN system)) (VP (VBD generated) (NP (NP (NNP Isoniazid) (HYPH -) (CD one)) (PP (IN of) (NP (DT the) (JJ main) (NNS drugs)))) (PP (IN for) (NP (NN Tuberculosis)))) (. .))
(S (NP (DT The) (NN system)) (VP (VBZ is) (ADVP (RB currently)) (VP (VBG being) (VP (VBN deployed) (PP (IN for) (NP (NP (NN use)) (PP (IN in) (NP (NN collaboration))))) (PP (IN with) (NP (JJ pharmaceutical) (NNS companies))) (S (VP (TO to) (ADVP (RB further)) (VP (VB analyze) (NP (ADJP (NP (DT the) (JJ additional)) (VBN generated)) (NNS molecules)))))))) (. .))
